
We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:


Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development SINGAPORE, BOSTON and SHANGHAI (June 28, 2022) – Cargene Biopharma Inc. ("Cargene”, the “Compan
SINGAPORE – 27 May 2022. EVX Ventures (“EVX”), a life sciences venture builder headquartered in Singapore with operations in Boston and Shanghai, today announces the official opening of EVX Nexus (“Ne
Advancing the next generation of cell and gene therapies via a “platform of platforms” model SINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the cl